NOTCH1 and B-cell chronic lymphocytic leukemia: Previous research has reported that the NOTCH1 mutation is a predictive factor for anti-CD20 monoclonal antibody resistance in chronic lymphocytic leukemia in a randomized chemo-immune therapy phase III trial (COMPLEMENT 1).36